How much is an Ogi stock worth?
The U.S.-listed shares of OrganiGram Holdings Inc. rose 0.7% in premarket trading Tuesday, after the Canada-based cannabis company reported a narrower fiscal second-quarter loss and revenue that ...
What does organigram Holdings Inc (Ogi) announce?
Find the latest OrganiGram Holdings Inc. (OGI) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
What does Ogi stand for?
Apr 12, 2022 · What happened. Canadian cannabis company Organigram Holdings ( OGI -3.95% ) reported its second-quarter fiscal 2022 earnings today, and investors liked what they saw. The …
Did organigram insiders sell or buy the stock?
Jan 13, 2022 · While other marijuana firms saw their price-to-earnings ratios spiral out of control, OGI stock stayed a little more grounded. It was a bit of a race between the tortoise and the …
How high will OGI stock go?
On average, analysts forecast that OGI's EPS will be -$0.09 for 2022, with the lowest EPS forecast at -$0.13, and the highest EPS forecast at -$0.06. On average, analysts forecast that OGI's EPS will be -$0.05 for 2023, with the lowest EPS forecast at -$0.06, and the highest EPS forecast at -$0.02.
Is OGI a stock to buy?
The financial health and growth prospects of OGI, demonstrate its potential to underperform the market. It currently has a Growth Score of C. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of F.
Is OGI being shorted?
Stock - Short Squeeze, Short Sale Volume, Borrow Rates, Fails-To-Deliver....Sign Up for a Forever Free Fintel Account.Short Interestshares - source: NASDAQShort Interest Ratio2.33 Days to Cover3 more rows
What is OGI stock forecast?
Stock Price Forecast The 12 analysts offering 12-month price forecasts for OrganiGram Holdings Inc have a median target of 2.36, with a high estimate of 4.20 and a low estimate of 1.78. The median estimate represents a +58.42% increase from the last price of 1.49.
Who owns OrganiGram holdings?
Major institutions are defined as firms or individuals that exercise investment discretion, over the assets of others, in excess of $100 Million....New and Sold Out Positions.OWNER NAMED. E. SHAW & CO., INC.SHARES HELD1,305,642CHANGE (SHARES)192,942CHANGE (%)17.34%VALUE (IN 1,000S)$2,27214 more columns
How to buy OGI stock?
Find the stock by name or ticker symbol – OGI – and research it before deciding if it's a good investment for you. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price. Check in on your investment.
When did OGI go public?
January 5, 2012OGI stock went public on January 5, 2012 and ended the day at $0.29. The stock has since gained 1,000%.Feb 14, 2020
Is OGI a buy 2021?
CIBC does not see either upside or downside right now giving OGI "" on their last update on May 11, 2021. The price target was set to 2.64+5.18....Predicted Opening Price for OrganiGram Holdings Inc. of Friday, April 8, 2022.Fair opening price April 8, 2022Current price$1.54$1.51 (Undervalued)
Is OrganiGram a buy right now?
9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last twelve months. There are currentl...
How has OrganiGram's stock price been impacted by COVID-19?
OrganiGram's stock was trading at $1.72 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO)....
When is OrganiGram's next earnings date?
OrganiGram is scheduled to release its next quarterly earnings announcement on Tuesday, April 12th 2022. View our earnings forecast for OrganiGram .
How were OrganiGram's earnings last quarter?
OrganiGram Holdings Inc. (NASDAQ:OGI) announced its quarterly earnings results on Tuesday, January, 11th. The company reported ($0.03) earnings per...
What price target have analysts set for OGI?
9 Wall Street analysts have issued 12-month price objectives for OrganiGram's shares. Their forecasts range from $2.25 to $5.30. On average, they a...
Who are OrganiGram's key executives?
OrganiGram's management team includes the following people: Beena G. Goldenberg , Chief Executive Officer & Director Nathalie Batten , Vice Pres...
Who are some of OrganiGram's key competitors?
Some companies that are related to OrganiGram include IVERIC bio (ISEE) , Ligand Pharmaceuticals (LGND) , ChemoCentryx (CCXI) , Prothena (PRTA)...
What other stocks do shareholders of OrganiGram own?
Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include KushCo (KSHB) , (CGC) ,...
What is OrganiGram's stock symbol?
OrganiGram trades on the NASDAQ under the ticker symbol "OGI."
A Look At The Intrinsic Value Of OrganiGram Holdings Inc. (TSE:OGI)
Organigram Holdings Inc. Files Final Base Shelf Prospectus
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of OrganiGram Holdings...
Organigram launches new 'SHRED'ems' lineup of cannabis-infused gummies
MONCTON, New Brunswick, August 31, 2021--Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today that it has obtained a receipt for a final short form base shelf prospectus (the "Base Shelf Prospectus") filed with the securities commissions in each of the provinces and territories of Canada.
Why Sundial Growers, Hexo, and OrganiGram Stocks Jumped Today
Organigram Holdings Inc. announced Wednesday the launch of its "SHRED'ems" lineup of "high-quality and bold" cannabis-infused gummies. The parent of Canada-based cannabis producer Organigram Inc., said "SHRED'ems" adds to its value-priced "SHRED" portfolio.
Organigram Launches Edison JOLTS, Reinvents the Ingestible Extract
There's been some good news in the Canadian cannabis sector recently, but it hasn't been reflected in several of the stocks. Shares of three Canadian growers are rebounding some today, however. The stocks of Hexo (NYSE: HEXO) and OrganiGram Holdings (NASDAQ: OGI) were up 9.3% and 7.3%, respectively, as of 2:05 p.m. EDT.
Hexo, MariMed And Cresco Labs Among Top Cannabis Stock Movers On August 16, 2021
MONCTON, New Brunswick, August 17, 2021--Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce the launch of Edison Cannabis Co. ("Edison") JOLTS, Canada’s first flavoured high potency THC lozenge.
Organigram Appoints Beena Goldenberg as Chief Executive Officer
GAINERS: Empower Clinics (OTC: EPWCF) shares closed up 12.66% at $0.33 with an estimated market cap of $108,509,916. Auxly Cannabis Group (OTC: CBWTF) shares closed up 12.36% at $0.21 with an estimated market cap of $177,682,423. MariMed (OTC: MRMD) shares closed up 9.18% at $0.96 with an estimated market cap of $310,074,237.
A Look At The Intrinsic Value Of OrganiGram Holdings Inc. (TSE:OGI)
MONCTON, New Brunswick, August 04, 2021--Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce Beena Goldenberg, formerly Chief Executive Officer of The Supreme Cannabis Company Inc.
Organigram launches new 'SHRED'ems' lineup of cannabis-infused gummies
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of OrganiGram Holdings...
Why Sundial Growers, Hexo, and OrganiGram Stocks Jumped Today
Organigram Holdings Inc. announced Wednesday the launch of its "SHRED'ems" lineup of "high-quality and bold" cannabis-infused gummies. The parent of Canada-based cannabis producer Organigram Inc., said "SHRED'ems" adds to its value-priced "SHRED" portfolio.
Hexo, MariMed And Cresco Labs Among Top Cannabis Stock Movers On August 16, 2021
There's been some good news in the Canadian cannabis sector recently, but it hasn't been reflected in several of the stocks. Shares of three Canadian growers are rebounding some today, however. The stocks of Hexo (NYSE: HEXO) and OrganiGram Holdings (NASDAQ: OGI) were up 9.3% and 7.3%, respectively, as of 2:05 p.m. EDT.
10 Best CBD Stocks to Invest In
GAINERS: Empower Clinics (OTC: EPWCF) shares closed up 12.66% at $0.33 with an estimated market cap of $108,509,916. Auxly Cannabis Group (OTC: CBWTF) shares closed up 12.36% at $0.21 with an estimated market cap of $177,682,423. MariMed (OTC: MRMD) shares closed up 9.18% at $0.96 with an estimated market cap of $310,074,237.
This Pot Stock Just Delivered a Monster Surprise for Investors
In this article, we will take a look at the 10 best CBD stocks to invest in. You can skip our comprehensive analysis of the cannabidiol market, and industry outlook for 2021 and go directly to the 5 Best CBD Stocks to Invest In. With the increase of sales, legalization, and medical and recreational benefits, […]
Why Hexo, Tilray, OrganiGram, and Sundial Stocks Are Wilting
It's safe to say that few expected a blowout third quarter from this relatively low-key New Brunswick operator.
Recently Viewed Tickers
As of 2 p.m. EDT Thursday, shares of marijuana stocks Hexo (NYSE: HEXO), OrganiGram Holdings (NASDAQ: OGI), Tilray (NASDAQ: TLRY), and Sundial Growers (NASDAQ: SNDL) are all sliding, down 4.7%, 2.6%, 2.4%, and 1.6%, respectively -- and the reason appears to be marijuana legalization.
OrganiGram Holdings Inc
Visit a quote page and your recently viewed tickers will be displayed here.
It's more likely than it sounds
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.
Why it might not double
Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing.
Why it's still possible
For a stock like OrganiGram to double in roughly six months, a sizable number of investors need to have a lot of confidence that the company in question is growing very rapidly. Such confidence typically needs to be confirmed and bolstered with new information in the form of favorable earnings reports or other positive developments.
The U.S. Cold War against cannabis is rapidly thawing
Despite the formidable headwinds to rapid growth, I think there's still a decent chance that OrganiGram could double again before the close of the year. First and foremost, management is predicting that the third fiscal quarter will go much better than the second.
What happened
Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.
So what
Nearly every major pot stock closed sharply higher on Monday. Tilray ( NASDAQ:TLRY), its partner-to-be Aphria ( NASDAQ:APHA), Aurora Cannabis ( NASDAQ:ACB), HEXO ( NASDAQ:HEXO), and OrganiGram Holdings ( NASDAQ:OGI) all rose at double-digit rates.
Now what
On Friday, the two chambers of Virginia's General Assembly passed marijuana legalization bills. The two must be reconciled for consistency's sake; afterward, the combined version will be sent to legalization supporter Gov. Ralph Northam for his signature.
